Zaire Ebola virus entry into human dendritic cells is insensitive to cathepsin L inhibition

51Citations
Citations of this article
78Readers
Mendeley users who have this article in their library.

Abstract

Cathepsins B and L contribute to Ebola virus (EBOV) entry into Vero cells and mouse embryonic fibroblasts. However, the role of cathepsins in EBOV-infection of human dendritic cells (DCs), important targets of infection in vivo, remains undefined. Here, EBOV-like particles containing a β-lactamase-VP40 fusion reporter and Ebola virus were used to demonstrate the cathepsin dependence of EBOV entry into human monocyte-derived DCs. However, while DC infection is blocked by cathepsin B inhibitor, it is insensitive to cathepsin L inhibitor. Furthermore, DCs pre-treated for 48 h with TNFα were generally less susceptible to entry and infection by EBOV. This decrease in infection was associated with a decrease in cathepsin B activity. Thus, cathepsin L plays a minimal, if any, role in EBOV infection in human DCs. The inflammatory cytokine TNFα modulates cathepsin B activity and affects EBOV entry into and infection of human DCs. © 2009 Blackwell Publishing Ltd.

Cite

CITATION STYLE

APA

Martinez, O., Johnson, J., Manicassamy, B., Rong, L., Olinger, G. G., Hensley, L. E., & Basler, C. F. (2010). Zaire Ebola virus entry into human dendritic cells is insensitive to cathepsin L inhibition. Cellular Microbiology, 12(2), 148–157. https://doi.org/10.1111/j.1462-5822.2009.01385.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free